Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

20 September 2020: Meta-Analysis

Efficacy and Toxicity of Adjuvant Therapies for High-Risk Endometrial Cancer in Stage I–III: A Systematic Review and Network Meta-Analysis

Mengyin Ao 12ABCDEF , Ting Ding 12BF , Dan Tang 12E , Mingrong Xi 12E*

DOI: 10.12659/MSM.925595

Med Sci Monit 2020; 26:e925595

Table 3 SUCRA values of 7 adjuvant therapies for high-risk endometrial cancer patients under 5 outcomes.

InterventionsSUCRA values (%)
Overall survivalProgression-free survivalDistant metastasisLocal recurrenceGrade III/IV late toxicities
A – pelvic radiotherapy; B – vaginal cuff brachytherapy and chemotherapy; C – pelvic radiotherapy and chemotherapy; D – no further treatment; E – chemotherapy; F – pelvic radiotherapy and vaginal brachytherapy; G – vaginal brachytherapy. NR – not reported.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750